ABO blood groups in COVID-19 patients; Cross-sectional study.


Journal

International journal of clinical practice
ISSN: 1742-1241
Titre abrégé: Int J Clin Pract
Pays: India
ID NLM: 9712381

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 22 10 2020
accepted: 01 12 2020
pubmed: 10 12 2020
medline: 7 4 2021
entrez: 9 12 2020
Statut: ppublish

Résumé

The aim of this study was to investigate the ABO and Rh blood group distribution and clinical characteristics in patients with COVID-19. The clinical characteristics and blood groups of 1667 patients who were hospitalised because of COVID-19 (with a positive PCR test) between 16 March and 10 July were reviewed cross-sectionally. When blood groups of patients diagnosed with COVID-19 and control group were compared, it was observed that there was an increase in the number of COVID-19 patients with blood groups A and AB, decrease in the number of COVID-19 patients with blood group O, a statistically significant increase in the number of individuals with blood group A in COVID-19 patients compared with healthy individuals, and almost significant increase in the number of COVID-19 patients with blood group AB and a very significant decrease in the number of COVID-19 patients with blood group O. Our study has found that having blood group O may be protective, that blood group A may have greater susceptibility to the disease, but this does not affect the course of the disease and is not associated with mortality.

Identifiants

pubmed: 33296536
doi: 10.1111/ijcp.13927
pmc: PMC7883261
doi:

Substances chimiques

ABO Blood-Group System 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13927

Informations de copyright

© 2020 John Wiley & Sons Ltd.

Références

J Ayub Med Coll Abbottabad. 2017 Jan-Mar;29(1):90-92
pubmed: 28712183
Nat Med. 2003 May;9(5):548-53
pubmed: 12692541
Clin Microbiol Rev. 2015 Jul;28(3):801-70
pubmed: 26085552
J Thromb Haemost. 2020 Apr;18(4):844-847
pubmed: 32073213
Nat Genet. 2009 Sep;41(9):986-90
pubmed: 19648918
Lancet Rheumatol. 2020 Jul;2(7):e437-e445
pubmed: 32835247
Br J Haematol. 2020 Jul;190(1):27-28
pubmed: 32420611
Circulation. 2016 Apr 12;133(15):1449-57; discussion 1457
pubmed: 26939588
J Thromb Haemost. 2008 Jan;6(1):62-9
pubmed: 17973651
Front Physiol. 2013 May 24;4:118
pubmed: 23745115
JAMA. 2005 Mar 23;293(12):1450-1
pubmed: 15784866
Int J Clin Pract. 2021 Apr;75(4):e13927
pubmed: 33296536
Turk J Med Sci. 2020 Jun 4;50(4):679-683
pubmed: 32496734
Clin Chim Acta. 2020 Oct;509:220-223
pubmed: 32562665
Transfusion. 2006 Oct;46(10):1836-44
pubmed: 17002642

Auteurs

İhsan Solmaz (İ)

Department of Internal Medicine, University of Health Sciences, Gazi Yasargil Training and Research Hospital, Diyarbakır, Turkey.

Songül Araç (S)

Department of Emergency Medicine, University of Health Sciences, Gazi Yasargil Training and Research Hospital, Diyarbakır, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH